Real-time enrollment status for this colorectal cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:43 AM UTC
| NCT Number | NCT05253651 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Cancer |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 132 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of October 15, 2026: Clinical trial NCT05253651 is currently recruiting participants. This phase3 study for colorectal cancer is actively seeking new participants at 132 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05253651 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 132 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05253651 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.